A very rare cancer in Down syndrome: Medulloblastoma. Epidemiological data from 13 countries

Journal of Neuro-Oncology

Volumn 112, Issue 1, 2013, Pages 107-114

  Satgé, Daniel ^a   Stiller, Charles A ^b   Rutkowski, Stefan ^c   Von Bueren, André O ^c   Lacour, Brigitte ^d   Sommelet, Danièle ^e   Nishi, Motoi ^f   Massimino, Maura ^g   Garré, Maria Luisa ^h   Moreno, Florencia ⁱ   Hasle, Henrik ^j   Jakab, Zsuzsanna ^k   Greenberg, Mark ^l   Von Der Weid, Nicolas ^m   Kuehni, Claudia ⁿ   Zurriaga, Oscar ^o   Vicente, Maria Luisa ^p   Peris Bonet, Rafael ^p   Benesch, Martin ^q   Vekemans, Michel ^r   Sullivan, Sheena G ^s   Rickert, Christian ^t   more..

^a UNIV MONTPELLIER   (France)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^d UNIVERSITY HOSPITAL OF NANCY   (France)

^e UNIVERSITÉ DE LORRAINE   (France)

^f HEALTH SCIENCES UNIVERSITY OF HOKKAIDO   (Japan)

^g NATIONAL CANCER INSTITUTE   (Italy)

^h G GASLINI INSTITUTE   (Italy)

ⁱ Registro Oncopediatrico Hospitalario Argentino   (Argentina)

^j AARHUS UNIVERSITY HOSPITAL   (Denmark)

^k SEMMELWEIS UNIVERSITY   (Hungary)

^l UNIVERSITY OF TORONTO   (Canada)

^m LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

ⁿ UNIVERSITY OF BERN   (Switzerland)

^o Area de Epidemiologia   (Spain)

^p UNIVERSITY OF VALENCIA   (Spain)

^q MEDICAL UNIVERSITY OF GRAZ   (Austria)

^r HÔPITAL NECKER ENFANTS MALADES   (France)

^s EDITH COWAN UNIVERSITY   (Australia)

^t Vivantes Clinic   (Germany)

more..

Author keywords

Brain tumor; Down syndrome; Glioma; Medulloblastoma; Natural protection against cancer; Primitive neurectodermal tumor

Indexed keywords

ADOLESCENT; ARTICLE; ASIA; ASTROCYTOMA; CANCER REGISTRY; CENTRAL NERVOUS SYSTEM TUMOR; CHILD; COMORBIDITY; CONTROLLED STUDY; CYTOGENETICS; DOWN SYNDROME; EPIDEMIOLOGICAL DATA; EUROPE; FEMALE; GEOGRAPHIC DISTRIBUTION; GLIOBLASTOMA; GLIOMA; GLIOSIS; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEDULLOBLASTOMA; NEUROECTODERM TUMOR; PACIFIC ISLANDS; PRESCHOOL CHILD; SCHOOL CHILD; TUMOR LOCALIZATION; WESTERN HEMISPHERE;

CEREBELLAR NEOPLASMS; CHILD; CHILD, PRESCHOOL; DOWN SYNDROME; FEMALE; HUMANS; MALE; MEDULLOBLASTOMA; WORLD HEALTH;

EID: 84874650077     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-012-1041-y     Document Type: Article

References (42)

1. Tabarés-Seisdedos R, Dumont N, Baudot A, Valderas JM, Climent J, Valencia A, Crespo-Facorro B, Vieta E, Gómez-Beneyto M, Martínez S, Rubenstein JL (2011) No paradox, no progress: inverse cancer comorbidity in people with other complex diseases. Lancet Oncol 12:604-608
2. Satgé D, Sommelet D, Geneix A, Nishi M, Malet P, Vekemans MJ (1998) A tumor profile in Down syndrome. Am J Med Genet 78:207-216 (Pubitemid 28307532)
3. Hasle H, Clemmensen IH, Mikkelsen M (2000) Risks of leukaemia and solid tumours in individuals with Down's syndrome. Lancet 355:165-169 (Pubitemid 30068214)
4. Sullivan SG, Hussain R, Glasson EJ, Bittles AH (2007) The profile and incidence of cancer in Down syndrome. J Intellect Disabil Res 51:228-231 (Pubitemid 46189568)
5. Satgé D, Monteil P, Sasco AJ, Vital A, Ohgaki H, Geneix A, Malet P, Vekemans MJ, Rethore M-O (2001) Aspects of intracranial and spinal tumors in patients with Down syndrome and report of a rapidly progressing grade 2 astrocytoma. Cancer 91:1458-1466 (Pubitemid 32319256)
6. Satgé D, Rickert CH (2009) A medical enigma: persons with Down syndrome do not develop medulloblastoma. Neuroepidemiology 32:164
7. Giangaspero F, Eberhart CG, Haapasalo H, Pietsch T, Wiestler OD, Ellison DW (2007) Medulloblastoma. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (eds) WHO classification of tumours of the central nervous system. Lyon, IARC, pp 132-140
8. McLendon RE, Judkins AR, Eberhart CG, Fuller GN, Sarkar C, Ng HK (2007) Central nervous system primitive neuroectodermal tumours. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (eds) WHO classification of tumours of the central nervous system. Lyon, IARC, pp 141-146
9. Rickert CH, Paulus W (2001) Epidemiology of central nervous system tumors in childhood and adolescence based on the new WHO classification. Childs Nerv Syst 17:503-511 (Pubitemid 32842704)
10. Stiller C (ed) (2007) Childhood cancer in Britain: incidence, survival, mortality. Oxford University Press, New York, pp 116-130
11. Satgé D, Sasco AJ, Carlsen NLT, Stiller CA, Rubie H, Hero B, De Bernardi B, De Kraker J, Coze C, Kogner P, Langmark F, Hakvoort-Cammel FGAJ, Beck D, Von Der Weid N, Parkes S, Hartmann O, Lippens RJJ, Kamps WA, Sommelet D (1998) A lack of neuroblastoma in Down syndrome: a study from 11 European countries. Cancer Res 58:448-452 (Pubitemid 28087405)
12. EUROCAT (European Registration of Congenital Anomalies) (1997) Down syndrome. In: 15 years surveillance of congenital anomalies in Europe: 1980-1994. EUROCAT Working Group, Brussels, pp 120-149
13. Khoshnood B, De Vigan C, Vodovar V, Goujard J, Goffinet F (2004) A population-based evaluation of the impact of antenatal screening for Down's syndrome in France, 1981-2000. BJOG 111:485-490 (Pubitemid 38621881)
14. Ekelund CK, Jorgensen FS, Petersen OB, Sundberg K, Tabor A (2008) Impact of a new national screening policy for Down's syndrome in Denmark: population-based cohort study. BMJ 337:a2547
15. Binkert F, Mutter M, Schinzel A (2002) Impact of prenatal diagnosis on the prevalence of live births with Down syndrome in the eastern half of Switzerland 1980-1996. Swiss Med Wkly 132:478-484 (Pubitemid 35407906)
16. Métneki J, Czeizel AE (2005) Increasing total prevalence rate of cases with Down syndrome in Hungary. Eur J Epidemiol 20:525-535 (Pubitemid 40933930)
17. Takeuchi A, Ehara H, Ohtani K, Maegaki Y, Nanba Y, Nagata I, Toyoshima M, Kondo A, Nakai S, Takeshita K, Ohno K (2008) Live birth prevalence of Down syndrome in Tottori, Japan, 1980-1999. Am J Med Genet A 146A:1381-1386 (Pubitemid 351770200)
18. Cocchi G, Gualdi S, Bower C, Halliday J, Jonsson B, Myrelid A, Mastroiacovo P, Amar E, Bakker MK, Correa A, Doray B, Melve KK, Koshnood B, Landau D, Mutchinick OM, Pierini A, Ritvanen A, Ruddock V, Scarano G, Sibbald B, Sípek A, Tenconi R, Tucker D, Annerén G (2010) International trends of Down syndrome 1993-2004: births in relation to maternal age and terminations of pregnancies. Birth Defects Res A 88:474-479
19. Carothers AD, Castilla EE, Dutra MG, Hook EB (2001) Search for ethnic, geographic, and other factors in the epidemiology of Down syndrome in South America: analysis of data from the ECLAMC project, 1967-1997. Am J Med Genet 103:149-156
20. Leonard S, Bower C, Petterson B, Leonard H (2000) Survival of infants born with Down's syndrome: 1980-96. Paediatr Perinat Epidemiol 14:163-171 (Pubitemid 30199252)
21. Glasson EJ, Sullivan SG, Hussain R, Petterson BA, Montgomery PD, Bittles AH (2002) The changing survival profile of people with Down's syndrome: implications for genetic counselling. Clin Genet 62:390-393 (Pubitemid 36372763)
22. Castilla EE, Rittler M, Dutra MG, Lopez-Camelo JS, Campaña H, Paz JE, Orioli IM (1998) Survival of children with Down syndrome in South America. ECLAMC-Downsurv Group. Latin American Collaborative Study of Congenital Malformations. Am J Med Genet 79:108-111
23. Benesch M, Moser A, Sovinz P, Lackner H, Schwinger W, Eder H, Urban C (2009) Medulloblastoma in a child with Down syndrome: long-term remission with multimodality treatment. Pediatr Blood Cancer 53:1150-1151
24. Satgé D, Créau N, Aflalo-Rattenbach R, Ducassou S, Lutz P, Bénard J (2008) Down syndrome's protection against neuroblastoma: the stromal and neural overmaturation tracks. In: Roux NE, Andre LH (eds) Focus on neuroblastoma research. Nova Sciences, New York, pp 57-100
25. Kaderali Z, Lamberti-Pasculli M, Rutka JT (2009) The changing epidemiology of paediatric brain tumours: a review from the Hospital for Sick Children. Childs Nerv Syst 25:787-793
26. Kaatsch P, Rickert CH, Kühl J, Schüz J, Michaelis J (2001) Population-based epidemiologic data on brain tumors in German children. Cancer 92:3155-3164 (Pubitemid 33136212)
27. Giangaspero F, Bigner SH, Giordana MT, Kleihues P, Trojanowski JQ (1997) Medulloblastoma. In: Kleihues P, Cavenee WK (eds) Pathology and genetics of tumours of the nervous system. IARC, Lyon, pp 96-103
28. Pfister S, Remke M, Toedt G, Werft W, Benner A, Mendrzyk F, Wittmann A, Devens F, von Hoff K, Rutkowski S, Kulozik A, Radlwimmer B, Scheurlen W, Lichter P, Korshunov A (2007) Supratentorial primitive neuroectodermal tumors of the central nervous system frequently harbor deletions of the CDKN2A locus and other genomic aberrations distinct from medulloblastomas. Genes Chromosomes Cancer 46:839-851 (Pubitemid 47106188)
29. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, Kleihues P (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114:97-109 (Pubitemid 47103521)
30. Bunin GR, Gallagher PR, Rorke-Adams LB, Robison LL, Cnaan A (2006) Maternal supplement, micronutrient, and cured meat intake during pregnancy and risk of medulloblastoma during childhood: a Children's Oncology Group study. Cancer Epidemiol Biomarkers Prev 15:1660-1667 (Pubitemid 44497102)
31. Northcott PA, Korshunov A, Witt H, Hielscher T, Eberhart CG, Mack S, Bouffet E, Clifford SC, Hawkins CE, French P, Rutka JT, Pfister S, Taylor MD (2011) Medulloblastoma comprises four distinct molecular variants. J Clin Oncol 29:1408-1414
32. Garrè ML, Cama A, Bagnasco F, Morana G, Giangaspero F, Brisigotti M, Gambini C, Forni M, Rossi A, Haupt R, Nozza P, Barra S, Piatelli G, Viglizzo G, Capra V, Bruno W, Pastorino L, Massimino M, Tumolo M, Fidani P, Dallorso S, Schumacher RF, Milanaccio C, Pietsch T (2009) Medulloblastoma variants: age-dependent occurrence and relation to Gorlin syndrome - a new clinical perspective. Clin Cancer Res 15:2463-2471
33. Saran A (2009) Medulloblastoma: role of developmental pathways, DNA repair signaling, and other players. Curr Mol Med 9:1046-1057
34. Ehara H, Ohno K, Ito H (2011) Benign and malignant tumors in Down syndrome: analysis of the 1514 autopsied cases in Japan. Pediatr Int 53:72-77
35. Grimmer MR, Weiss WA (2006) Childhood tumors of the nervous system as disorders of normal development. Curr Opin Pediatr 18:634-638 (Pubitemid 44747156)
36. Mensah A, Mulligan C, Linehan J, Ruf S, O'Doherty A, Grygalewicz B, Shipley J, Groet J, Tybulewicz V, Fisher E, Brandner S, Nizetic D (2007) An additional human chromosome 21 causes suppression of neural fate of pluripotent mouse embryonic stem cells in a teratoma model. BMC Dev Biol 7:131
37. Reynolds LE, Watson AR, Baker M, Jones TA, D'Amico G, Robinson SD, Joffre C, Garrido-Urbani S, Rodriguez-Manzaneque JC, Martino-Echarri E, Aurrand-Lions M, Sheer D, Dagna-Bricarelli F, Nizetic D, McCabe CJ, Turnell AS, Kermorgant S, Imhof BA, Adams R, Fisher EM, Tybulewicz VL, Hart IR, Hodivala-Dilke KM (2010) Tumour angiogenesis is reduced in the Tc1 mouse model of Down's syndrome. Nature 465:813-817
38. Kim WY, Lee HY (2009) Brain angiogenesis in developmental and pathological processes: mechanism and therapeutic intervention in brain tumors. FEBS J 276:4653-4664
39. Baxter LL, Moran TH, Richtsmeier JT, Troncoso J, Reeves RH (2000) Discovery and genetic localization of Down syndrome cerebellar phenotypes using the Ts65Dn mouse. Hum Mol Genet 9:195-202 (Pubitemid 30052743)
40. Roper RJ, Baxter LL, Saran NG, Klinedinst DK, Beachy PA, Reeves RH (2006) Defective cerebellar response to mitogenic Hedgehog signaling in Down [corrected] syndrome mice. Proc Natl Acad Sci U S A 103:1452-1456 (Pubitemid 43191186)
41. Yabut O, Domogauer J, D'Arcangelo G (2010) Dyrk1A overexpression inhibits proliferation and induces premature neuronal differentiation of neural progenitor cells. J Neurosci 30:4004-4014
42. Peris-Bonet R, Martínez-García C, Lacour B, Petrovich S, Giner-Ripoll B, Navajas A, Steliarova-Foucher E (2006) Childhood central nervous system tumours - incidence and survival in Europe (1978-1997): report from the Automated Childhood Cancer Information System Project. Eur J Cancer 42:2064-2080 (Pubitemid 44224055)